Cronus Pharma: Anased Equine Injection (xylazine Injection) 100 Mg/ml, Sedative
AnaSed Equine Injection Recall Summary Cronus Pharma is recalling AnaSed Equine Injection (xylazine injection) 100 mg/mL, a sedative for horses, due to product discoloration reported by customers. The affected product is a 50 mL injection distributed nationwide across all U.S. states. This is a Class II recall, meaning the product could cause adverse health effects.
- Recalling firm
- Cronus Pharma
- Product
- AnaSed Equine Injection (xylazine injection) 100 mg/mL, Sedative, 50 mL, Manufactured for: Cronus Pharma LLC, East Brunswick, NJ 08816, Made in India, NDC 69043-043-05; NADA 140-442; For intravenous (IV) or intramuscular (IM) use in horses only.
- Reason
- Due to market complaints pertaining to product discoloration.
- Classification
- Class II
- Category
- food recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-09-22
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/ac4f691f-f6b9-4e45-a365-c087a5dfc8b4